PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 54 min ago
18/04/2019
Until now, scientists have had only a limited number of tools for working out the cause of an individual’s tumour.
18/04/2019
For adults who have failed to respond to, or are unsuitable for, other systemic therapies.
18/04/2019
The legal right to choice has been in place for over a decade, but just 48% of the public are currently aware of it.
18/04/2019
PureTech Health will receive up to $26 million under the transaction.
17/04/2019
Tickets are available for those wanting to be a part of one of the most important dates in the clinical research calendar – an evening of celebration and recognition for the very best clinical researchers from across the globe
17/04/2019
The Phase III STR1VE data showed that 21 patients were alive and event-free as of September 27 last year.
17/04/2019
The deal successfully concludes a research collaboration between LifeArc, Oxford University’s Nuffield Department of Clinical Neurosciences and Daiichi Sankyo.
17/04/2019
95% of those treated in the study were found to have a complete remission rate.
17/04/2019
The decision will allow patients in England with the rare, inherited, severely debilitating and fatal disease to access the treatment on the NHS.
17/04/2019
The decision is primarily based on Phase III data from the HAWK and HARRIER trials.
16/04/2019
The PharmaTimes Clinical Researcher of the Year – The Americas gala dinner & awards ceremony will be taking place at the Sheraton Hotel in Boston on 4th May.
16/04/2019
The results will enable researchers to perform an objective technology evaluation of the various market offerings in liquid biopsy in the second stage.
16/04/2019
The research identified seven existing drugs - either already in development or being used to treat other conditions.
16/04/2019
The public-private partnership aims to provide a cost-effective technological innovation.
16/04/2019
Over 6,250 care homes have already signed up to the system, which is accessible on any device.
16/04/2019
The three-year extension is part of a £30 million investment in a national programme for General Practice Development.
16/04/2019
The decision was based on a clinical trial showing an objective response rate of 32.2%.
16/04/2019
The decision was won by a majority of more than 75%.
15/04/2019
Available information is often outdated and sometimes inaccurate.
15/04/2019
The data provides the first significant update in nearly 20 years regarding slowing the progression of CKD in patients with type II diabetes.
Pages
